NETSPOT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Netspot, and what generic alternatives are available?
Netspot is a drug marketed by Aaa Usa Inc and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-two patent family members in nineteen countries.
The generic ingredient in NETSPOT is gallium dotatate ga-68. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium dotatate ga-68 profile page.
DrugPatentWatch® Generic Entry Outlook for Netspot
Netspot was eligible for patent challenges on June 1, 2020.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be August 10, 2032. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NETSPOT?
- What are the global sales for NETSPOT?
- What is Average Wholesale Price for NETSPOT?
Summary for NETSPOT
| International Patents: | 32 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 5 |
| Drug Prices: | Drug price information for NETSPOT |
| What excipients (inactive ingredients) are in NETSPOT? | NETSPOT excipients list |
| DailyMed Link: | NETSPOT at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for NETSPOT
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for NETSPOT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hoag Memorial Hospital Presbyterian | Phase 2 |
| RayzeBio, Inc. | Phase 2 |
| Assistance Publique - Hôpitaux de Paris | Phase 3 |
US Patents and Regulatory Information for NETSPOT
NETSPOT is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of NETSPOT is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting NETSPOT
Process for the preparation of complexes of .sup.68Ga
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NETSPOT
When does loss-of-exclusivity occur for NETSPOT?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Australia
Patent: 12297008
Patent: Process for the preparation of complexes of 68GA
Estimated Expiration: ⤷ Sign Up
Brazil
Patent: 2014003336
Patent: processo para a preparação de complexos de 68ga
Estimated Expiration: ⤷ Sign Up
Patent: 2020011908
Patent: PROCESSO PARA A PREPARAÇÃO DE COMPLEXOS DE 68GA
Estimated Expiration: ⤷ Sign Up
Canada
Patent: 44145
Patent: PROCEDE POUR LA PREPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA)
Estimated Expiration: ⤷ Sign Up
Patent: 45484
Patent: PROCEDE POUR LA PREPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA)
Estimated Expiration: ⤷ Sign Up
China
Patent: 3889930
Patent: Process for the preparation of complexes of 68ga.
Estimated Expiration: ⤷ Sign Up
Colombia
Patent: 20857
Patent: Procedimiento para la preparación de complejos de 68ga
Estimated Expiration: ⤷ Sign Up
Denmark
Patent: 42017
Estimated Expiration: ⤷ Sign Up
European Patent Office
Patent: 42017
Patent: PROCÉDÉ POUR LA PRÉPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA)
Estimated Expiration: ⤷ Sign Up
Patent: 55168
Patent: PROCÉDÉ POUR LA PRÉPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA)
Estimated Expiration: ⤷ Sign Up
Patent: 18991
Patent: PROCÉDÉ POUR LA PRÉPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA)
Estimated Expiration: ⤷ Sign Up
India
Patent: 97CHN2014
Estimated Expiration: ⤷ Sign Up
Israel
Patent: 0904
Patent: תהליך להכנת קומפלקסים של גאליום -68 (Process for the preparation of complexes of 68ga)
Estimated Expiration: ⤷ Sign Up
Patent: 5849
Patent: תהליך להכנת איזוטופ קומפלקסים של 68ga (Process for the preparation of complexes of 68ga.)
Estimated Expiration: ⤷ Sign Up
Patent: 5979
Patent: תהליך להכנת קומפלקסים של 68ga (Process for the preparation of complexes of 68ga)
Estimated Expiration: ⤷ Sign Up
Italy
Patent: 20110180
Patent: PROCESSO PER LA PREPARAZIONE DI COMPLESSI DI 68GA.
Estimated Expiration: ⤷ Sign Up
Japan
Patent: 61610
Estimated Expiration: ⤷ Sign Up
Patent: 14524423
Estimated Expiration: ⤷ Sign Up
Mexico
Patent: 0081
Patent: PROCEDIMIENTO PARA LA PREPARACION DE COMPLEJOS DE 68GA. (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA.)
Estimated Expiration: ⤷ Sign Up
Patent: 14001691
Patent: PROCEDIMIENTO PARA LA PREPARACION DE COMPLEJOS DE 68GA. (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA.)
Estimated Expiration: ⤷ Sign Up
New Zealand
Patent: 2071
Patent: Process for the preparation of complexes of 68ga.
Estimated Expiration: ⤷ Sign Up
Patent: 8281
Patent: Process for the preparation of complexes of 68ga
Estimated Expiration: ⤷ Sign Up
Poland
Patent: 42017
Estimated Expiration: ⤷ Sign Up
Portugal
Patent: 42017
Estimated Expiration: ⤷ Sign Up
Russian Federation
Patent: 05090
Patent: СПОСОБ ПОЛУЧЕНИЯ КОМПЛЕКСОВGa (METHOD OFGa COMPLEXES PRODUCTION)
Estimated Expiration: ⤷ Sign Up
Patent: 14109381
Patent: СПОСОБ ПОЛУЧЕНИЯ КОМПЛЕКСОВGa
Estimated Expiration: ⤷ Sign Up
Patent: 16144237
Patent: СПОСОБ ПОЛУЧЕНИЯ КОМПЛЕКСОВ 68Ga
Estimated Expiration: ⤷ Sign Up
Patent: 20120802
Patent: СПОСОБ ПОЛУЧЕНИЯ КОМПЛЕКСОВ 68Ga
Estimated Expiration: ⤷ Sign Up
South Africa
Patent: 1401789
Patent: PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA
Estimated Expiration: ⤷ Sign Up
Spain
Patent: 60231
Estimated Expiration: ⤷ Sign Up
Patent: 35581
Estimated Expiration: ⤷ Sign Up
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering NETSPOT around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| New Zealand | 708281 | Process for the preparation of complexes of 68ga | ⤷ Sign Up |
| New Zealand | 622071 | Process for the preparation of complexes of 68ga. | ⤷ Sign Up |
| European Patent Office | 3718991 | PROCÉDÉ POUR LA PRÉPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA) | ⤷ Sign Up |
| Brazil | 122020011908 | PROCESSO PARA A PREPARAÇÃO DE COMPLEXOS DE 68GA | ⤷ Sign Up |
| Spain | 2560231 | ⤷ Sign Up | |
| Canada | 2844145 | PROCEDE POUR LA PREPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA) | ⤷ Sign Up |
| Australia | 2012297008 | Process for the preparation of complexes of 68GA | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
